Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



SA anti-trust authority recommends Nestlé-Pfizer Nutrition deal

By Mark Astley , 06-Feb-2013

SA anti-trust authority recommends Nestlé-Pfizer Nutrition deal

The South African Competition Commission has given its blessing to Nestlé’s $11.85bn global acquisition of Pfizer Nutrition – leaving it in the hands of the country’s Competition Tribunal to approve the deal.

If approved in South Africa, the merged company would hold a significant share of the country’s infant formula market. The Competition Commission is concerned that the price of infant formula could increase in the country as a result.

It has recommended that the Competition Tribunal approves the acquisition, but only under the condition that Nestlé re-brands Pfizer Nutrition infant formula products for a total of 20 years.

It has also recommended that these re-branded infant formula products are licenced to a third party for the period.

“Alleviate” potential competition concerns

"In order to alleviate the potential competition concerns without compelling the new merged company to sell of the existing Pfizer brands of infant formula, the Competition Commission has recommended a transitional re-branding remedy lasting two consecutive 10-year periods during which time Nestlé will licence out the existing Pfizer products for sale under different brand names to an independent licensee.”

“After the 20 year period, Nestlé may re-introduce the Pfizer brand with their original branding into the market. The Competition Commission is of the view that this transitional re-branding remedy has benefits which a permanent divestiture lacks and which outweigh the inherent risks normally associated with re-branding.”

The Competition Commission added that rival infant formula manufacturers in the country have indicated that the proposed acquisition could raise “serious competition concerns.”

The Competition Tribunal hearing in regards to the deal took place earlier today.

Closed, but awaiting approval

The deal was filed in a total of 15 countries and has so far been cleared in a total of 10, including China, India, Brazil and Ireland. Australian authorities also approved the transaction, but with conditions.

The Mexican Federal Competition Commission (CFC) is the only authority to prohibit the transaction so far.

Despite awaiting regulatory approval from a number of countries, the $11.85bn deal was completed in December 2012 after it was approved by the “majority of markets involved.”

A spokesperson for Nestlé told at the time, that the deal had been approved in more than 85% of the markets Pfizer Nutrition operates in – allowing its closure under the terms of the April 2012 acquisition agreement.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars